Healthcare tech firm CareCloud's Q3 revenue up 9%, beats expectations

Carecloud

06/11/2025 12:29

Overview

CareCloud Q3 revenue rises 9% yr/yr, beating analyst expectations

Company raises full-year 2025 revenue guidance to $117-$119 mln

CareCloud completes Medsphere acquisition, accelerates AI initiatives

Outlook

CareCloud raises full-year 2025 revenue guidance to $117-$119 mln

Company expects full-year 2025 adjusted EBITDA of $26-$28 mln

CareCloud projects full-year 2025 EPS of $0.10-$0.13

Result Drivers

ACQUISITIONS - Completion of Medsphere acquisition and others contributed to revenue growth and market expansion

AI INITIATIVES - AI integration into platforms enhanced performance and opened new sales opportunities

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$31.10 mln
$28.62 mln (3 Analysts)
Q3 EPS
$0.04
Q3 Adjusted Net Income
$4.40 mln
Q3 Adjusted EBITDA
$7.70 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the software peer group is "buy"

Wall Street's median 12-month price target for CareCloud Inc is $6.00, about 50.8% above its November 5 closing price of $2.95

The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 18 three months ago

Press Release: ID:nGNXbSFQC5

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)